Strategic partnerships Medichem is actively expanding collaborations, evidenced by recent license and supply agreements with Somerset Therapeutics and a strategic partnership with Breckenridge Pharmaceutical. This indicates openness to OEM/CMO, licensing, and co-development opportunities that a sales team can leverage to propose joint manufacturing, API supply, or FDF partnerships.

Global footprint With a presence across the USA, Malta, China, and other locations and serving over 600 corporate clients in 60+ countries, Medichem offers a broad global reach for distributors, contract manufacturing, and cross-border supply arrangements. This makes them a viable partner for regional expansion, regulatory support, and international sourcing programs.

Sustainability leadership Awarded COASHIQ Sustainability Awards for waste, water, and climate change programs and launching Board 2030 initiatives, Medichem demonstrates a strong sustainability program. This presents an opportunity to align value propositions around green APIs, sustainable supply chains, and ESG-compliant product development to attract customers with sustainability mandates.

Chlorhexidine leader Medichem is recognized as a world leader in Chlorhexidine-based products, strengthening its position in a high-demand antiseptic segment. This offers targeted sales pitches to pharmaceutical manufacturers and distributors seeking reliable chlorhexidine APIs or finished dosage forms, especially for markets with stringent antiseptic requirements.

Generics and services The portfolio spans ~45 APIs and 20 FDFs with end-to-end services including R&D, contract manufacturing, and licensing. This breadth supports upsell opportunities to existing clients for expanded API/FDF portfolios, contract manufacturing capacity, and licensing deals, as well as introductions to new clients seeking integrated development-to-supply solutions.